Notably, NF-κB inhibition—a key regulator of inflammatory gene transcription—highlights its therapeutic relevance in gastric inflammation and carcinogenesis (Kim et al., 2021; Bahrami et al., 2024). Here, NFKB1 is linked to inflammation.